﷿﷿﷿﷿﷿﷿﷿﷿﷿﷿﷿﷿﷿﷿﷿﷿﷿﷿﷿﷿﷿﷿﷿﷿
00垞ꁺ噧츁﷿灰敵﷿噧﷿ꊔ쵶សၞ灰腿赻థ⸥䊕Vidaza for Inj. 100mg츁蘤땜繕햅睭HK-55407, Vidaza﷿﷿褤㵝ᑸ嬰掠薈陞㥸钙䍎腿赻థ⸥䊕Bicnu for Inj. 100mg츁蘤땜繕햅睭HK-05144﷿, Busulfex Inj. 6mg/ml츁蘤땜繕햅睭HK-50627﷿, Caelyx Conc for Infusion 2mg/ml츁蘤땜繕햅睭HK-43397﷿ 썹Velcade for Inj. 3.5mg츁蘤땜繕햅睭HK-53329﷿慲䭢炙鎙﷿﷿쉰먰岄Ben Venue Laboratories츁Ben Venue﷿℄큩踤鉺䭢蒂ᵸ肟鉺炙鎙ǿ
00垞コ⸥䊕쥕恳﷿镺漰Ben Venue袘㑦﷿灰敵궑₌灰⩧㹥흢陋쉰⸥䊕쥕蒂ꆔ흟慲䭢蒂ᵸ䁚靥﷿纆㑩䑑﷿踤鉺₌Ben Venue℄ᝓ橸숰䭢蒂ᵸ肟鉺炙鎙﷿斗⢞颗푚陋佧퍫ⱜ酭邔字킆ǿ﷿䎛䲞﷿Ben Venueඟⷿ⩠佧皑℄陋䁗慲⸥䊕﷿褤꾗㑩ᒐ皑⩧㑩踤鉺佧퍫䭢蒂ᵸ䁚靥慲炙鎙ǿ
00袘㦑斈佧﷿腿蘤땜⸥澂晭츁Ź肀﷿乣Ben Venue晭硱ǿ䑑艔腿⸥䊕﷿ږ㦑ǿᒐ륞艔腿⸥䊕䑑﷿Neurolite for Inj with Buffer Vial츁蘤땜繕햅睭HK-43086, Neurolite﷿陋Cardiolite for Inj츁蘤땜繕햅睭HK-43085﷿₌袘㦑﷿筞佧㉚뢍﷿NeuroliteŖꁺ㑦橕敵큩ꊔ쵶សၞǿ
00Vidaza颗乣Ben Venue陋豸慲Baxter Oncology GmbH﷿乣踤鉺慲炙鎙扠嵗山Ben Venue﷿㡸扠សၞ乣Ben Venue慲Vidazaǿ
00Vidaza乣陫䙚⸥䊕踤몎늗牬⸥쑲츁ږ㦑﷿佧㑜﷿ւ츁늗牬﷿ǿ﷿ւ豿론ﲁ﷿2011㑦斈1,144㔄﷿ᔥ쐃蒂흟﷿罒菱롭﷿罒菱陋⸥ǿ늗牬굧頤晔칶츁2817 1616﷿﷿ស⮞佧퍫㑩﷿ǿ垞﷿쥕សၞ䲈﷿ǿ
00㥸钙䍎腿褤₌褐ᔰ鉺ᑻS佧ᔥ쐃慲⸥䊕﷿睭Bicnu for Inj. 100mg﷿Busulfex Inj. 6mg/ml﷿Caelyx Conc for Infusion 2mg/ml 陋 Velcade for Inj. 3.5mgǿ
00踤ᵓ鎐睭湭乣鉺ᑻ褐ᔰ筞佧⸥䊕統륞䍎腿⸥䊕﷿﷿ᅮ纆ᐰ慲੨﷿﷿륞Ⱕ⸥䊕S垇큩䡑﷿颗䝎쒀ǿ₌๏㦕델﷿鉺⸥ᐰ荬作ᑻ﷿쐃ə㥒皑Ⱕ⸥䊕慲摱ꔃ힀䕥륞Ⱕ⸥䊕慲㮟₌鲖ǿ詟﷿詟쐃₌荬作ᐰᑻ餢륞Ⱕ⸥䊕ǿŖ쐃媂쪂쥕鉺륞䍎腿⸥䊕慲ᐰ﷿₌踤鉺詟䉒癣쐃ꞆṖ퍫㚂﷿炙鎙ᑻ츁ꢙ﷿蔤﷿﷿쐃欁袟璍ǿ쉗
00湭ꁺ﷿垞筞佧轔镺㍺供佧퍫慲詟䉒癣쐃欁ፚǿ쉗
00垞踤౨嬰掠﷿롭蒂ᵸ흟﷿罒菱롭﷿㡸陋嬰ᜱ쑲葧ǿ垞Ŗ쑜﷿ཿ钙쥕蒂葧﷿㡸灰늋蚀梙蝳陋蝳﷿踤큢ǿ
噦
뭳썗㑦敵뭳㡞噧츁ݒҌ﷿
ږ㦑ᑻ籭뭳뭳ᑻ앢婿䁗